The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s bone growth stimulator market report forecasts the bone growth stimulator market size to grow to $2.04 Billion by 2027, with a CAGR (compound annual growth rate) of more than 8%.

Learn More On The Bone Growth Stimulator Market Report 2023 – https://www.thebusinessresearchcompany.com/report/bone-growth-stimulator-global-market-report

Bone Growth Stimulator Market Size Forecast
The global bone growth stimulator market is expected to grow from $1.37 billion in 2022 to $1.47 billion in 2023 at a compound annual growth rate (CAGR) of 7.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The bone growth stimulator market size is expected to grow to $2.04 billion in 2027 at a CAGR of 8.5%.

North America held the largest bone growth stimulator market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Bone Growth Stimulator Market Driver ­– Rise In Number Of Bone Fractures
For instance, Amgen, a US-based biotechnology company, presented numbers in May 2022 stating that osteoporosis causes around 1.5 million fractures annually in the United States, resulting in $19 billion in associated expenses. In addition, it is predicted that from 2018 to 2040, there would be a 68% increase in the number of osteoporotic fractures every year, from 1.9 million to 3.2 million. Therefore, the rise in the number of bone fractures is expected to drive the bone growth stimulator market.

Request for A Sample Of The Global Bone Growth Stimulator Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6885&type=smp

Key Bone Growth Stimulator Market Trend – Technological Advancement
Electrical Bone Growth Stimulation (EBGS) is a unique approach to accelerate healing and promote fusion success rates. Increased experience and widespread EBGS devices have led to significant advancements in stimulation paradigms and clinical outcomes. For instance, in February 2020, Orthofix, a US-based medical device company, has announced approval by the US Food and Drug Administration (FDA) for the use of technologically advanced bone growth stimulators named STIM onTrack™ mobile app version 2.1 that works with the Orthofix Bone Growth Therapy devices allowing patients to remotely communicate with their doctor about their quality of life and functional well-being.

Bone Growth Stimulator Market Segment
1) By Type: Bone Growth Stimulation Devices, Bone Morphogenetic Proteins (BMP), Platelet-Rich Plasma (PRP) Therapy
2) By Type Of Use: Implantable Device, External Device
3) By Application: Fractures, Spinal Fusion, Osteogenesis, Arthrodesis Treatment, Spondylolithesis
4) By End User: Hospitals & ASCs, Speciality Clinics, Home Care

Bone Growth Stimulator Market Major Players and Strategies
Major players in the bone growth stimulator market are Arthrex Inc., DJO Global Inc., Stryker Corporation, Bioventus Inc., Zimmer Biomet Holdings Inc., Medtronic plc, Orthofix Holdings Inc., Depuy Synthes, Terumo BCT Inc., Isto Biologics, Johnson & Johnson, Ossatec Benelux BV, Elizur Corporation, ITO Co. Ltd., BTT Health GmbH, Stimulate Health, Kinex Medical Company LLC, Fintek Bio-Electric Inc., Regen Lab SA and Altis Biologics (Pty) Ltd.

In March 2021, Binoventus, a US-based innovations for an active healing company, acquired Bioness Inc. for $45 million in up-front consideration with up to $65 million after achieving the particular milestone. With this acquisition, Bioventus will receive the entire portfolio of bioness products, including its research and development pipeline that offer bone healing, bone graft efficacy to treat osteoarthritis. Bioness Inc. is a Spain-based medical equipment manufacturing company.

The Bone Growth Stimulator Global Market Report 2023 covers regional data on bone growth stimulator market size, bone growth stimulator market trends and drivers, opportunities, strategies, and bone growth stimulator market competitor analysis. The countries covered in the bone growth stimulator market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The bone growth stimulator is an electrical osteogenesis stimulator used to boost the natural fusion of bone after a fracture. The purpose of BGS is to send more energy to the healing bone surface through either pulsed electromagnetic or ultrasound. The electromagnetic field allows attracting the two oppositely charged ends of the bones to each other by stimulating new bone growth and fusion, which leads to healing. The bone growth stimulator is used to boost bone healing for difficult to heal fractures or fusions through applying ultrasonic or electrical current to the fracture/fusion site.

View More Reports Related To The Bone Growth Stimulator Market –
Bone Grafts And Substitutes Global Market Report 2023
Bone Densitometer Global Market Report 2023
Bone And Joint Health Supplements Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: